Results of search for 'au:"Orquiza, Michael D" ' › MedStar Authors Catalog catalog

Results
	1.	The Utility of "Blind" 131I treatments for differentiated thyroid cancer: an educational exhibit. MedStar authors: Orquiza, Michael D Van Nostrand, Douglas Year: 2013 Citation: 2013/06/08/ Department: Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Elboga U, Orquiza M, Celen Y, Aktolun C, Van Nostrand D Local accession number: 2013_234 Add to cart (remove)
	2.	The utility of "blind" 131I treatments for differentiated thyroid cancer (DTC): an educational exhibit MedStar authors: Orquiza, Michael D Van Nostrand, Douglas Year: 2013 Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Orquiza M, Elboga U, Zeki C, Aktolun C, Van Nostrand D Local accession number: 2013_8 Add to cart (remove)
	3.	Guidelines for the indications for 131 I remnant ablation on differentiated thyroid cancer: a distillation and comparison of guidelines from seven organizations. MedStar authors: Khorjekar, Gauri Orquiza, Michael D Van Nostrand, Douglas Year: 2013 Citation: 2013/06/08/ Department: Department of Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Guan H, Van Nostrand D, Li Y, Orquiza M, Teng W, Khorjekar G Local accession number: 2013_161 Add to cart (remove)
	4.	Guidelines for the indications for 131I remnant ablation on differentiated thyroid cancer: a distillation and comparison of guidelines from seven organizations. MedStar authors: Khorjekar, Gauri Orquiza, Michael D Van Nostrand, Douglas Year: 2013 Citation: 2013/06/08/ Department: Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Guan H, Van Nostrand D, Li Y, Orquiza M, Teng W, Khorjekar G Local accession number: 2013_235 Add to cart (remove)
	5.	Guidelines for the indications for 131I remnant ablation on differentiated thyroid cancer: a distillation and comparison of guidelines from seven organizations MedStar authors: Khorjekar, Gauri Orquiza, Michael D Van Nostrand, Douglas Year: 2013 Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Orquiza M, Guan H, Van Nostrand D, Li Y, Teng W, Khorjekar G Local accession number: 2013_7 Add to cart (remove)
	6.	The utility of "Blind" 131 I treatment for differentiated thyroid cancer: an educational exhibit. MedStar authors: Elboga, Umut Orquiza, Michael D Van Nostrand, Douglas Year: 2013 Citation: 2013/06/08/ Department: Department of Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Elboga U, Orquiza M, Celen Y, Aktolun C, Van Nostrand D Local accession number: 2013_160 Add to cart (remove)
	7.	Guidelines for the prescribed activity for 131 I remnant ablation on differentiated thyroid cancer: a distillation and comparison of guidelines from seven organizations. MedStar authors: Khorjekar, Gauri Orquiza, Michael D Van Nostrand, Douglas Year: 2013 Citation: 2013/06/08/ Department: Department of Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Guan H, Van Nostrand D, Li Y, Orquiza M, Teng W, Khorjekar G Local accession number: 2013_162 Add to cart (remove)
	8.	Guidelines for the prescribed activity for 131I remnant ablation on differentiated thyroid cancer: a distillation and comparison of guidelines from seven organizations. MedStar authors: Khorjekar, Gauri Orquiza, Michael D Van Nostrand, Douglas Year: 2013 Citation: 2013/06/08/ Department: Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Guan H, Van Nostrand D, Li Y, Orquiza M, Teng W, Khorjekar G Local accession number: 2013_236 Add to cart (remove)
	9.	Characterization of salivary gland side effects up to 7 days after 131I therapy: final report of the thyroid cancer survivors' association, inc. (ThyCa) national survey MedStar authors: Hall, Jordan Khorjekar, Gauri Mete, Mihriye Orquiza, Michael D Year: 2013 Institution: MedStar Health Research Institute MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Orquiza M, Hall J, Khorjekar G, Brennan M, McIver B, Mete M, Bloom G Local accession number: 2013_7 Add to cart (remove)
	10.	124I-NaI PET/CT based 3-D radiobiological Dosimetry (3D-RD) for 131I-NaI therapy of metastatic well-differentiated thyroid cancer. MedStar authors: Atkins, Frank Khorjekar, Gauri Orquiza, Michael D Van Nostrand, Douglas Van Nostrand, Douglas Year: 2013 Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Atkins F, Khorjekar G, Orquiza MD Local accession number: 2013_2 Add to cart (remove)
	11.	Evaluation of lithium as adjunctive treatment of 131I therapy for differentiated thyroid cancer: an educational exhibit MedStar authors: Khorjekar, Gauri Orquiza, Michael D Van Nostrand, Douglas Wartofsky, Leonard Year: 2013 Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Orquiza M, Van Nostrand D, Khorjekar G, Elboga U, Guan H, Wartofsky L Local accession number: 2013_7 Add to cart (remove)
	12.	#Alpharadinr #(Xofigor) in the treatment of skeletal metastasis secondary to metastatic prostate cancer: an educational exhibit. MedStar authors: Duong, Eric Khorjekar, Gauri Orquiza, Michael D Van Nostrand, Douglas Year: 2013 Citation: 2013/06/08/ Department: Department of Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Duong E, Orquiza M, Khorjekar G, Van Nostrand D Local accession number: 2013_159 Add to cart (remove)
	13.	Alpharadinr in the treatment of skeletal metastasis secondary to metastatic prostate cancer: an educational exhibit. MedStar authors: Duong, Eric Khorjekar, Gauri Orquiza, Michael D Van Nostrand, Douglas Year: 2013 Citation: 2013/06/08/ Department: Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Duong E, Orquiza M, Khorjekar G, Van Nostrand D Local accession number: 2013_233 Add to cart (remove)
	14.	124 I-Nal PET/CT Based 3-D radiobiological dosimetry (3D-RD) for 131I-Nal therapy of metastatic well-differentiated thyroid cancer. MedStar authors: Atkins, Frank Khorjekar, Gauri Orquiza, Michael D Van Nostrand, Douglas Year: 2013 Citation: 2013/06/08/ Department: Department of Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Senthamizhchelvan S, Hobbs R, Atkins F, Khorjekar G, Orquiza M, Van Nostrand D, Sgouros G Local accession number: 2013_166 Add to cart (remove)
	15.	Whole body retention of 131I at 24hr versus 48hr as a predictor of maximum tolerated activity (MTA). MedStar authors: Atkins, Frank Orquiza, Michael D Van Nostrand, Douglas Wartofsky, Leonard Year: 2013 Citation: 2013/06/08/ Department: Medicine/Endocrinology Medicine/Nuclear Medicine Form of publication: Poster Presentation Local accession number: 2013_231 Add to cart (remove)
	16.	Alpharadinr in the treatment of skeletal metastasis secondary to metastatic prostate cancer: an educational exhibit MedStar authors: Duong, Eric Khorjekar, Gauri Orquiza, Michael D Van Nostrand, Douglas Year: 2013 Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Orquiza M, Duong E, Khorjekar G, Van Nostrand D Local accession number: 2013_7 Add to cart (remove)
	17.	Whole body retention of I-131 at 24hr vs. 48hr as a predictor of maximum tolerated activity (MTA). MedStar authors: Atkins, Frank Orquiza, Michael D Van Nostrand, Douglas Wartofsky, Leonard Year: 2013 Citation: 2013/06/08/ Department: Department of Medicine/Endocrinology Department of Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Atkins F, Van Nostrand D, Orquiza M, Wartofsky L Local accession number: 2013_158 Add to cart (remove)
	18.	Characterization of salivary gland side effects secondary to 131I therapy: final report of the thyroid cancer survivors' association, inc. (ThyCa) national survey for intermediate and long term results MedStar authors: Hall, Jordan Khorjekar, Gauri Mete, Mihriye Orquiza, Michael D Van Nostrand, Douglas Year: 2013 Institution: MedStar Health Research Institute MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Orquiza M, Hall J, Van Nostrand D, Khorjekar G, Brennan M, McIver B, Mete M, Bloom G Local accession number: 2013_7 Add to cart (remove)
	19.	Characterization of salivary gland side effects up to 7 days after 131I therapy: final report of the Thyroid Cancer Survivors" Association, Inc. (ThyCa) National Survey for Intermediate and Long Term Results. MedStar authors: Hall, Jordan Khorjekar, Gauri Mete, Mihriye Orquiza, Michael D Van Nostrand, Douglas Year: 2013 Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Orquiza MH, Hall JP, Van Nostrand D, Khorjekar G, Brennan M, McIver B, Mete M, Bloom G Local accession number: 2013_2 Add to cart (remove)
	20.	Correlation of 124I PET dosimetry with clinical response of 131I therapy (Tx) for metastatic differentiated thyroid cancer (DTC) MedStar authors: Atkins, Frank Garcia, Carlos Khorjekar, Gauri Mete, Mihriye Orquiza, Michael D Van Nostrand, Douglas Wartofsky, Leonard Year: 2013 Institution: MedStar Health Research Institute MedStar Washington Hospital Center Washington Cancer Institute Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Khorjekar G, Senthamizhchelvan S, Hobbs R, Orquiza M, Atkins F, Mete M, Garcia C, Wartofsky L, Sgouros G, Van Nostrand D Local accession number: 2013_4 Add to cart (remove)
	21.	Correlation of 124I PET dosimetry with clinical response of 131I therapy (Tx) for Metastatic Differentiated Thyroid Cancer (DTC). MedStar authors: Atkins, Frank Garcia, Carlos Khorjekar, Gauri Mete, Mihriye Orquiza, Michael D Van Nostrand, Douglas Wartofsky, Leonard Year: 2013 Institution: MedStar Health Research Institute MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Khorjekar G, Orquiza MD, Atkins F, Mete M, Garcia C, Wartofsky L, Van Nostrand D Local accession number: 2013_2 Add to cart (remove)
	22.	Correlation of 124 I PET dosimetry with clinical response of 131 I therapy for metastatic differentiated thyroid cancer. MedStar authors: Atkins, Frank Garcia, Carlos Khorjekar, Gauri Mete, Mihriye Orquiza, Michael D Van Nostrand, Douglas Wartofsky, Leonard Year: 2013 Institution: MedStar Health Research Institute MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Khorjekar G, Senthamizhchelvan S, Hobbs R, Orquiza M, Atkins F, Mete M, Garcia C, Wartofsky L, Sgouros G, Van Nostrand D Local accession number: 2013_16 Add to cart (remove)
	23.	Characterization of sialoadenitis after administration of continous sialogogues during the day and night After 131 I therapy. MedStar authors: Acio, Elmo Burman, Kenneth D Garcia, Carlos Khorjekar, Gauri Kulkarni, Kanchan Orquiza, Michael D Schneider, Mark Wartofsky, Leonard Year: 2013 Citation: 2013/06/08/ Department: Department of Medicine/Endocrinology Department of Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Orquiza M, Khorjekar G, Schneider M, Kulkarni K, Garcia C, Acio E, Burman K, Wartofsky L Local accession number: 2013_165 Add to cart (remove)
	24.	Characterization of Sialoadenitis (SA) after administration of continuous Sialogogues (SGs) during the day and night after 131I therapy (tx). MedStar authors: Acio, Elmo Burman, Kenneth D Garcia, Carlos Khorjekar, Gauri Kulkarni, Kanchan Orquiza, Michael D Schneider, Mark Wartofsky, Leonard Year: 2013 Citation: 2013/06/08/ Department: Medicine/Endocrinology Medicine/Nuclear Medicine Form of publication: Poster Presentation Local accession number: 2013_230 Add to cart (remove)
	25.	Retrospective study of the utility of 18F sodium fluoride PET bone scans in patients with thyroid cancer with suspected bone metastases. MedStar authors: Burman, Kenneth D Garcia, Carlos O'Neil, Jeffrey Orquiza, Michael D Schneider, Mark Van Nostrand, Douglas Wartofsky, Leonard Wexler, Jason Year: 2013 Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Orquiza M, Schneider M, Garcia C, O'Neil J, Van Nostrand D, Wexler J, Burman K, Wartofsky L Local accession number: 2013_2 Add to cart (remove)
	26.	Retrospective study of the utility of 18F sodium fluoride PET bone scans in patients with differentiated thyroid cancer with suspected bone metastases MedStar authors: Burman, Kenneth D Garcia, Carlos O'Neil, Jeffrey Orquiza, Michael D Schneider, Mark Van Nostrand, Douglas Wartofsky, Leonard Wexler, Jason Year: 2013 Institution: MedStar Washington Hospital Center Department: Medicine/Endocrinology Medicine/Nuclear Medicine Form of publication: Conference All authors: Orquiza M, Schneider M, Garcia C, O'Neil J, Van Nostrand D, Wexler J, Burman K, Wartofsky L Local accession number: 2013_8 Add to cart (remove)
	27.	Characterization of sialoadenitis (SA) after administration of continuous sialogogues (SGs) during the day and night after 131I therapy (tx) MedStar authors: Acio, Elmo Burman, Kenneth D Garcia, Carlos Khorjekar, Gauri Kulkarni, Kanchan Orquiza, Michael D Schneider, Mark Van Nostrand, Douglas Wartofsky, Leonard Year: 2013 Institution: MedStar Washington Hospital Center Department: Medicine/Endocrinology Medicine/Nuclear Medicine Form of publication: Conference All authors: Orquiza M, Khorjekar G, Schneider M, Kulkarni K, Garcia C, Acio E, Burman K, Wartofsky L, Van Nostrand D Local accession number: 2013_7 Add to cart (remove)

Refine your search

Authors

Item types

Collections

Languages

Your search returned 27 results.